The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Genetic Control of Isoniazid Metabolism in Man
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis.
Hughes, H. B., Biehl, J., Jones, A., & Schmidt, L. H. (1954) · PubMed · doi:10.1164/art.1954.70.2.266 · Cited by 225
Tuberculosis Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid
Selikoff, I. J., & Robitzek, E. H. (1952) · Diseases of the Chest · doi:10.1378/chest.21.4.385 · Cited by 94
Robitzek, E. H., SELIKOFF, I. J., & Ornstein, G. G. (1952) · PubMed · Cited by 63
Imperfection: Biochemical Phobias and Metabolic Ambivalence
Drabkin, D. L. (1959) · Perspectives in biology and medicine · doi:10.1353/pbm.1959.0037 · Cited by 39
Cited by
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Weinshilboum, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020021 · Cited by 1,031
Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine
Roden, D., Pulley, J., Basford, M., Bernard, G., Clayton, E., Balser, Jr., & Masys, D. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.89 · Cited by 983
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17709-5 · Cited by 942
Metadata
- Authors
- Evans, D. A. P., Manley, K. A., & McKusick, V. A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1960-08-13
- Volume
- 2
- Issue
- 5197
- Pages
- 485-491
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2093714545
- Cited by
- 784
- References
- 4
- FWCI
- 23.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.